Inventor · disambiguated record
Arne Mork
Also filed as: MORK ARNE
4 granted patents·12 pending applications·60 citations·filing 2002–2014
81Inventor score
Top patents by PatentIndex Score
16 records- 0194US8722684B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentBANG-ANDERSEN BENNY·Filed 2007·Granted May 13, 2014·31 cites·8 claims
- 0292US9125908B21-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·11 cites·10 claims
- 0391US9125909B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·9 cites·11 claims
- 0491US9125910B21-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairmentLUNDBECK & CO AS H·Filed 2014·Granted Sep 8, 2015·9 cites·10 claims
- 0564US2009176808A1combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonistLUNDBECK & CO AS H·Filed 2009·Application pending·0 cites
- 0661US2008004338A1Use of enantiomeric pure escitalopramLUNDBECK & CO AS H·Filed 2007·Application pending·0 cites
- 0757US2007105843A1Combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonistLUNDBECK & CO AS H·Filed 2006·Application pending·0 cites
- 0853US2004192766A1Use of enantiomeric pure escitalopramLUNDBECK & CO AS H·Filed 2003·Application pending·0 cites
- 0953US2004198811A1Use of enantiomeric pure escitalopramLUNDBECK & CO AS H·Filed 2003·Application pending·0 cites
- 1053US2004192764A1Use of enantiomeric pure escitalopramLUNDBECK & CO AS H·Filed 2003·Application pending·0 cites
- 1153US2004198810A1Use of enantiomeric pure escitalopramLUNDBECK & CO AS H·Filed 2003·Application pending·0 cites
- 1253US2004192765A1Use of enantiomeric pure escitalopramLUNDBECK & CO AS H·Filed 2003·Application pending·0 cites
- 1349US2003032636A1Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonistLUNDBECK & CO AS H·Filed 2002·Application pending·0 cites
- 1448US2004198809A1Use of enantiomeric pure escitalopramFiled 2002·Application pending·0 cites
- 1545US2009054510A1Method for identifying compounds for the treatment of depressionLUNDBECK & CO AS H·Filed 2007·Application pending·0 cites
- 1637US2005288355A1Combination therapy wherein a serotonin reuptake inhibitor is usedMORK ARNE·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arne Mork files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →